Quarterly Activities/Appendix 4C Cash Flow Report

Open PDF
Stock Skin Elements Ltd (SKN.ASX)
Release Time 30 Apr 2025, 4:23 p.m.
Price Sensitive Yes
 Quarterly Activities/Appendix 4C Cash Flow Report
Key Points
  • ECO-Nurture sustainable, horticultural plant bio stimulant trials on kiwi fruit orchards in New Zealand nearing completion
  • SuprCuvr disinfectant formula continues evaluation as a 3 in 1 cleaner and disinfectant in public health and transport sectors
  • Review of packaging design and formulation underway for large-scale distribution opportunity for a white label Soléo Organics sunscreen product
Full Summary

Skin Elements Limited (ASX: SKN) has presented its Quarterly Activity Report for the period ending 31 March 2025. Key highlights include:- ECO-Nurture sustainable, horticultural plant bio stimulant trials on kiwi fruit orchards in New Zealand are nearing completion ahead of planned commercial roll-out in H2 2025. The company plans to expand ECO-Nurture into other crop lines, including grapes, apples and pears.- The SuprCuvr disinfectant formula continues evaluation as a 3 in 1 cleaner and disinfectant in public health and transport sectors, with the product being used on train carriages in Melbourne. Skin Elements will seek to leverage other opportunities for the commercial-scale use of SuprCuvr.- A review of packaging design and formulation is underway in respect of a large-scale distribution opportunity for a white label Soléo Organics sunscreen product in the retail pharmacy sector. The company is also working on the development of a new, premium SPF50 Soléo Organics sunscreen for the domestic market.- The company completed a successful non-renounceable rights issue, raising $656k, including $143k in oversubscriptions. This provided strong validation of Skin Elements' product development and commercialization plans.- Skin Elements continues to progress Phase 2 improvements in the PapayaActivs formulation and expansion of the product range, while also undertaking small scale Phase 3 test marketing of skincare ranges.The company's commitment to research and development is reflected in the receipt of a $133k R&D Rebate advance during the quarter.